Results 181 to 190 of about 23,778 (225)

Advances in Electrocardiogram‐Based Non‐Invasive Blood Glucose Monitoring Technology

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4445-4463, June 2026.
ABSTRACT Blood glucose monitoring is fundamental to diabetes management, yet traditional invasive methods are limited by patient discomfort and infection risks. In recent years, electrocardiogram (ECG), a conventional tool for cardiovascular assessment, has gained attention as a prospective method for non‐invasive blood glucose monitoring.
Qi Zeng, Jiaying Ni, Ziyi Zhang, Jinghao Cai, Jingyi Lu, Jian Zhou   +5 more
wiley   +1 more source

Targeted Therapies in Infantile Hemangiomas and Vascular Malformations: From β-Blockers to PI3K/AKT/mTOR Inhibitors. [PDF]

J Cell Mol Med
Arasiewicz H, Dec M.
europepmc   +1 more source

A Tri‐Culture Heart‐on‐a‐Chip Platform With iPSC‐Derived Cardiac Cells for Predictive Cardiotoxicity Testing

Advanced Healthcare Materials, Volume 15, Issue 18, 15 May 2026.
This study presents the first entirely isogenic heart‐on‐chip, unifying cardiomyocytes, fibroblasts, and endothelial cells from a single iPSC source. The platform reveals a critical biological insight: the endothelium actively shields cardiac tissue from drug‐induced toxicity, challenging the predictive accuracy of conventional, avascular models for ...
Karine Tadevosyan, Jose Yeste, Mar Alvarez, Denise Marrero, Laura Casado‐Medina, Yvonne Richaud‐Patin, Olalla García‐Iglesias, Jagoda Litowczenko, Alba Morillas Garcia, Anton Guimerà, Xavi Illa, Rosa Villa, Angel Raya   +12 more
wiley   +1 more source

Antihypertensive Drugs and Dental Caries Risk: A Drug-Target Mendelian Randomization Analysis. [PDF]

Int J Genomics
Shi W, Liu S, Wu X, Cheng W, Jia X, Hu Z.   +5 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies

Advanced Science, Volume 13, Issue 25, 4 May 2026.
The schematic diagram illustrates the roles of novel immune checkpoints, immunomodulatory factors, cell death and multimodal technologies in cancer immunotherapy. Abstract Cancer immunotherapy has redefined cancer treatment. However, the molecular and cellular basis of immune evasion and therapeutic resistance remains incompletely understood.
Fangquan Chen, Yang Yu, Xiutao Cai, Junhao Lin, Ruirui Liang, Rui Kang, Daolin Tang, Jiao Liu   +7 more
wiley   +1 more source

The neural niche in cancer: mechanistic insights into tumor-neuron-immune crosstalk and therapeutic opportunities. [PDF]

Front Cell Dev Biol
Aysit N, Altintas E, Koksalar Alkan F, Ozturk G, Korkaya H.   +4 more
europepmc   +1 more source

Bedside risk score for medical therapy failure in small‐volume BPH: Temporal validation

BJUI Compass, Volume 7, Issue 5, May 2026.
Abstract Purpose Medical therapy is the first‐line treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). However, predictors of treatment failure in men with small prostate volume (<30 ml) remain poorly defined.
Numan Alam, Naveed Ahmad, Syed Hamzah Shirazi, Aftab Ahmed, Bilal Suria, Jamahid Ali, Muhammad Anas Ghazi, Elham Shenawa, Mirza Muhammad Hadeed Khawar   +8 more
wiley   +1 more source

Upstream CB1R Regulation of β-Adrenergic Memory Consolidation. [PDF]

Hippocampus
Rossato JI, Ribeiro L, Lima-Silva T, Araujo R, Orvate R, Azevedo AL, Bevilaqua Cammarota N, Baracho AL, Carneiro L, Cammarota M.   +9 more
europepmc   +1 more source

The Immune Landscape of Acral Melanoma: From Basic to Clinical

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Acral melanoma (AM) is an aggressive melanoma subtype with poor prognosis and limited response to immune checkpoint inhibitors (ICIs). Despite increasing research efforts, the mechanisms underlying therapeutic resistance remain incompletely understood.
Lihong Jiang, Zhaotian Zhang
wiley   +1 more source

Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with Erlotinib. [PDF]

Medicina (Kaunas)
Yıldız O, Aykut T, Kaya BE, Genç Ö, Gürbüz AF, Saçkan F, Eryılmaz MK, Koçak MZ, Araz M, Artaç M.   +9 more
europepmc   +1 more source